Evidence map›Paper›PMID 42461246›Full record

ArticleCell biology international2026

Cytokeratin Detection in Lymphoid Tumor Cell Lines: Implications for Flow Cytometry and Molecular Analyses.

Natsuko Mizutani, Shiori Takeuchi, Akemi Koyanagi, Takeshi Hirano, Yumi Kumagai, Manoho Okabe, Kanade Asou, Komai Kido, Haruka Kayano, Yuki Shimazu and 4 more

Abstract read
In one paragraph

Article in Cell biology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Natsuko MizutaniDepartment of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-0875-8508
Shiori TakeuchiDepartment of Immunological Diagnosis, Atopy (Allergy) Research center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Akemi KoyanagiDepartment of Research Support Center, Laboratory of Cell Biology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5418-2303
Takeshi HiranoDepartment of Immunological Diagnosis, Atopy (Allergy) Research center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yumi KumagaiDepartment of Biochemistry and Systems Biomedicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Manoho OkabeDepartment of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan.
Kanade AsouDepartment of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan.
Komai KidoDepartment of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan.
Haruka KayanoDepartment of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan.
Yuki ShimazuDepartment of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan.
Momoko IchikawaDepartment of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan.
Rio KatoDepartment of Medical Technology, Faculty of Health Sciences, Kyorin University, Tokyo, Japan.
Yasuhiko ItoDepartment of Immunological Diagnosis, Atopy (Allergy) Research center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shuji MatsuokaDepartment of Immunological Diagnosis, Atopy (Allergy) Research center, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytokeratins are widely used as epithelial markers in diagnostic pathology and flow cytometry, and malignant lymphomas are generally considered cytokeratin-negative except for undifferentiated large cell lymphomas. During antibody screening experiments using flow cytometry, intracellular cytokeratin signals were unexpectedly detected in cultured lymphoma cell lines after cell permeabilization. Although cytokeratin is a component of the cytoskeleton, this finding raised concerns regarding the interpretation of cytokeratin positivity in lymphoid cells. To elucidate the nature of cytokeratin detection in lymphomas, cultured T-cell, B-cell, and natural killer cell lymphoma lines were analyzed using immunohistochemistry, flow cytometry, and quantitative RT-PCR (qRT-PCR), with epithelial carcinoma cell lines and keratin-free cells as references. Because malignant lymphomas disseminate systemically, we examined whether this behavior was associated with epithelial-mesenchymal transition-like features. Cytokeratins were not detected on the cell surface of lymphoid or epithelial cells but were detected intracellularly in multiple lymphoma cell lines. qRT-PCR confirmed the expression of multiple keratin transcripts in lymphoid cells, without correlation with epithelial-mesenchymal transition-related markers, including CDH1. These findings indicate that intracellular cytokeratin detection can occur in lymphoma cell lines without evidence of epithelial differentiation or association with EMT-related markers and should be considered when interpreting cytokeratin positivity.

Indexed as

KeratinsLymphomaBiomarkers, TumorCell Line, TumorEpithelial-Mesenchymal TransitionFlow CytometryHumansImmunohistochemistryBiomarkers, TumorKeratinscytokeratinflow cytometryimmunocytochemistryintermediate filamentsintracellular staininglymphoid tumorquantitative RT‐PCR (qRT‐PCR)

Identifiers

PMID42461246
PMCPMC13374590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.